Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A benign or malignant neoplasm with neuroendocrine differentiation that arises from the larynx. This category includes paraganglioma, carcinoid tumor, small cell carcinoma, and large cell neuroendocrine carcinoma.
Biomarker and diagnostic research for laryngeal neuroendocrine neoplasm has been reported in the published literature.
No clinical trials have been registered for laryngeal neuroendocrine neoplasm.
87 publications have been identified in PubMed for laryngeal neuroendocrine neoplasm. Research spans Case Report / Case Series (30%), Basic Science / Preclinical (18%), and Review / Meta-Analysis (16%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 26 | 30% |
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 3:07 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Laboratory research
16 |
18% |
Research summaries | 14 | 16% |
Clinical study results | 11 | 13% |
Disease patterns and progression | 10 | 11% |
Testing and diagnosis research | 9 | 10% |
Other research | 1 | 1% |
Marrable L (2026). [PMID: 41818868](https://pubmed.ncbi.nlm.nih.gov/41818868/). *Int J Pediatr Otorhinolaryngol*. [Diagnostic / Biomarker]
Liu Y (2026). [PMID: 41991984](https://pubmed.ncbi.nlm.nih.gov/41991984/). *Sci Rep*. [Basic Science / Preclinical]
Mogitate M (2026). [PMID: 42263404](https://pubmed.ncbi.nlm.nih.gov/42263404/). *Auris Nasus Larynx*. [Diagnostic / Biomarker]
Kozhanov AL (2026). [PMID: 41764096](https://pubmed.ncbi.nlm.nih.gov/41764096/). *Vestn Otorinolaringol*. [Case Report / Case Series]
Mladenovic N (2026). [PMID: 41969617](https://pubmed.ncbi.nlm.nih.gov/41969617/). *Case Rep Pathol*. [Case Report / Case Series]
You YS (2026). [PMID: 42259063](https://pubmed.ncbi.nlm.nih.gov/42259063/). *Auris Nasus Larynx*. [Epidemiology / Natural History]
Sato K (2026). [PMID: 41991388](https://pubmed.ncbi.nlm.nih.gov/41991388/). *J Voice*. [Review / Meta-Analysis]
Benfadil D (2026). [PMID: 41438668](https://pubmed.ncbi.nlm.nih.gov/41438668/). *Radiology case reports*. [Case Report / Case Series]
Zhang HL (2026). [PMID: 42135050](https://pubmed.ncbi.nlm.nih.gov/42135050/). *Zhonghua Yi Xue Za Zhi*. [Epidemiology / Natural History]
Kunieda C (2026). [PMID: 42168029](https://pubmed.ncbi.nlm.nih.gov/42168029/). *J Voice*. [Diagnostic / Biomarker]
AI-curated news mentioning laryngeal neuroendocrine neoplasm
Updated Jul 20, 2026
A 15-year study reveals that the pathological subtype of laryngeal neuroendocrine neoplasms significantly influences patient survival and failure patterns. This research provides critical insights for tailoring treatment strategies in affected individuals.